RecruitingNCT07497308

GDF-15 and Early Outcomes After LVAD Implantation

Association of Preoperative GDF-15 Levels With Early Postoperative Outcomes and Mortality After LVAD Implantation


Sponsor

Akdeniz University

Enrollment

48 participants

Start Date

Feb 4, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This observational study aims to investigate the association between preoperative GDF-15 levels and early postoperative outcomes in patients undergoing left ventricular assist device (LVAD) implantation. The study will evaluate whether elevated preoperative GDF-15 levels are associated with adverse early outcomes, including postoperative complications and mortality. The findings may help improve preoperative risk assessment and identify high-risk patients before LVAD implantation.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with advanced heart failure and left ventricular assist device implantation. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Akdeniz University, Faculty of Medicine, Department of Anesthesiology and Reanimation

Antalya, Please Select:, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07497308


Related Trials